The heart rate hypothesis: Ready to be tested

Heart

Volumn 94, Issue 5, 2008, Pages 561-565

  Hall, Alistait S ^a,c   Palmer, S ^b  

^a UNIVERSITY OF LEEDS   (United Kingdom)

^b UNIVERSITY OF YORK   (United Kingdom)

^c LEEDS GENERAL INFIRMARY   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ANGIOTENSIN RECEPTOR ANTAGONIST; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CALCIUM ANTAGONIST; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; DIURETIC AGENT; IVABRADINE;

ACUTE HEART INFARCTION; ANGINA PECTORIS; ATHEROSCLEROSIS; ATHEROSCLEROTIC PLAQUE; CARDIOVASCULAR DISEASE; CARDIOVASCULAR RISK; CORONARY ARTERY DISEASE; CORONARY ARTERY OBSTRUCTION; HEART ARRHYTHMIA; HEART FAILURE; HEART INFARCTION; HEART MUSCLE ISCHEMIA; HEART RATE; HUMAN; HYPERTENSION; ISCHEMIC HEART DISEASE; MORBIDITY; MORTALITY; NONHUMAN; OXYGEN CONSUMPTION; PATHOPHYSIOLOGY; PRIORITY JOURNAL; PROGNOSIS; REVIEW; STABLE ANGINA PECTORIS; SUDDEN DEATH;

ADULT; ANGINA PECTORIS; ATHEROSCLEROSIS; CLINICAL TRIALS AS TOPIC; CORONARY ARTERY DISEASE; DEATH, SUDDEN, CARDIAC; FEMALE; GREAT BRITAIN; HEART RATE; HUMANS; MALE; MIDDLE AGED; MYOCARDIAL ISCHEMIA; OXYGEN CONSUMPTION; RISK FACTORS; TACHYCARDIA; TREATMENT OUTCOME;

EID: 42549092076     PISSN: 13556037     EISSN: None     Source Type: Journal    
DOI: 10.1136/hrt.2007.118760     Document Type: Review

References (39)

1. British Heart Foundation. Coronary heart disease statistics. 2003.
2. Shaper A, Cook D, Walker M, et al. Prevalence of ischaemic heart disease in middle aged British men. Br Heart J 1984;51:595- 605.
3. Gandhi M, Lampe F, Wood DA, et al. Incidence, clinical characteristics, and short-term prognosis of angina pectoris. Br Heart J 1995;73:193-8.
4. Staniforth A. Evidence based treatment of chronic stable angina. Int J Cardiol 1998;63:21-5.
5. Swedberg K, Kjekshus J, Snapinn S. Long-term survival in severe heart failure in patients treated with enalapril. Eur Heart J 1999;20:136-9.
6. Kjekshus J. Heart rate reduction-a mechanism of benefit. Eur Heart J 1987;8 (Suppl L):115-22.
7. Kjekshus J. Importance of heart rate in determining beta-blocker efficacy in acute and long-term acute myocardial infarction intervention trials. Am J Cardiol 1986;57:43F-49F.
8. Gordon D, Guyton J, Karnovsky N. Intimal alterations in rat aorta induced by stressful stimuli. Lab Invest 1981;45:14-27.
9. Beere PA, Glagov S, Zarins CK. Retarding effect of lowered heart rate on coronary atherosclerosis. Science 1984;226:180-2.
10. Perski A, Harnstein K, Lindvall K, et al. Heart rate correlates with severity of coronary atherosclerosis in young post-infarction patients. Am Heart J 1988;116:1369-73.
11. Andrews T, Fenton T, Glasser SP, et al. Subsets of ambulatory myocardial ischemia based on heart rate activity. Orcadian distribution and response to anti-ischemic medication. Circulation 1993;88:92-100.
12. Pratt C, McMahon R, Goldstein S, et al. Comparison of subgroups assigned to medical regimens used to suppress cardiac ischaemia (the Asymptomatic Cardiac Ischemia Pilot [ACIP] Study). Am J Cardiol 1996;77:1302-9.
13. Cleophas T, van der Sluijs J, van der Vring JA, et al. Combination of calcium channel blockers and beta-blockers for patients with exercise-induced angina pectoris: Beneficial effect of calcium channel blockers largely determined by the effect on heart rate. J Clin Pharmacol 1999;39:738-46.
14. Dyer A, Persky V, Stamler J, et al. Heart rate as a prognostic factor for coronary heart disease and mortality: Findings in three Chicago epidemiological studies. Am J Epidemiol 1980;112:736-48.
15. Shaper A, Wannamethee G, Macfarlane PW, et al. Heart rate, ischaemic heart disease, and sudden cardiac death in middle-aged British men. Br Heart J 1993;70:49-55.
16. Gillum R, Makuc D, Feldman JJ, et al. Pulse rate, coronary heart disease, and death: The NHANES I Epidemiological Follow-up Study. Am Heart J 1991;121:172-7.
17. Benetos A, Rudnichi A, Thomas F, et al. Influence of heart rate on mortality in a French population. Role of age, gender, and blood pressure. Hypertens 1999;33:44-52.
18. Kannel W, Kannel C, Paffenberger RS, et al. Heart rate and cardiovascular mortality: The Framingham Study. Am Heart J 1987;113:1489-94.
19. Jouven X, Empana J-P, Schwartz PJ, et al. Heart-rate profile during exercise as a predictor of sudden death. New Engl J Med 2005;352:1951-8.
20. Mensink G, Hoffmeister H. The relationship between resting heart rate and all-cause, cardiovascular and cancer mortality. Eur Heart J 1997;18:1404-10.
21. Chang M, Havlik RJ, Corti M-C, et al. Relation of heart rate at rest and mortality in the women's health and aging study. Am J Cardiol 2003;92:1294-9.
22. Aronow W, Ahn C, Mercando AD, et al. Association of average heart rate on 24-hour ambulatory electrocardiograms with incidence of new coronary events at 48-month follow-up in 1,311 patients (mean age 81 years) with heart disease and sinus rhythm. Am J Cardiol 1996;78:1175-6.
23. Palatini P. Heart rate as a cardiovascular risk factor. Eur Heart J Supplements 1999;1(suppl B): B3-B9.
24. Gillman M, Kannel W, Belanger A, et al. Influence of heart rate on mortality among persons with hypertension: The Framingham Study. Am Heart J 1993;125:1148-54.
25. Farinaro E, Stranges S, Guglielmucci G, et al. Heart rate as a risk factor in hypertensive individuals. The Italian TensioPulse Study. Nutr Metab Cardiovasc Dis 1999;9:196-202.
26. Palatini P, Thijs L, Staessen JA, et al. Predictive value of clinic and ambulatory heart rate for mortality in elderly subjects with systolic hypertension. Arch Intern Med 2002;162:2313-21.
27. Jelinek V, McDonald I. History, exercise test, and prognosis of chest pain. Med J Aust 1980;2:25-7.
28. Diaz A, Bourassa MG, Guertin M-C, et al. Long-term prognostic value of resting heart rate in patients with suspected or proven coronary artery disease. Eur Heart J 2005;26:967-74.
29. Hjalmarson A, Gilpin E, Kjekshus J, et al. Influence of heart rate on mortality after acute myocardial infarction. Am J Cardiol 1990;65:547-53.
30. Disegni E, Goldbourt U, Reicher-Reiss H, et al. The predictive value of admission heart rate on mortality in patients with acute myocardial infarction. J Clin Epidemiol 1995;48:1197-1205.
31. Lechat P, Hulot J-S, Escolano S, et al. Heart rate and cardiac rhythm relationships with bisprolol benefit in chronic heart failure in CIBIS II Trial. Circulation 2001;103:1428-33.
32. Nul D, Doval H, et al. Heart rate is a marker of amiodarone mortality reduction in severe heart failure. JACC 1997;29:1199- 1205.
33. Kaplan JR, Manuck SB, Adams MR, et al. Inhibition of coronary atherosclerosis by propanolol in behaviourally predisposed monkeys fed an atherogenic diet. Circulation 1987;76:1364-72.
34. Brown MD, Davies MK, Hudlicka O. The effect of long term bradycardia on heart microvascular supply and performance. Cell Mol Biol Res 1994;40:137-42.
35. Ferrari R, Nesta F, Boraso A. Increased heart rate is detrimental: the myocardial metabolic theory. Eur Heart J 1999;1(suppl H):H24-H28.
36. Lechat P. Beta-blocker treatment in heart failure. Role of heart rate reduction. Basic Res Cardiol 1998;93(suppl 1):148-55.
37. Baigent C, Keech A, Kearney PM, et al. Efficacy and safety of cholesterol-lowering treatment: prospective meta-analysis of data from 90,056 participants in 14 randomised trials of statins. Lancet 2005;366:1267-78.
38. Turnbull F, Blood Pressure Lowering Treatment Trialists' Collaboration. Effects of different blood-pressure-lowering regimens on major cardiovascular events: results of prospectively-designed overviews of randomised trials. Lancet 2003;362:1527-35.
39. Fox KM, Ferrari R, Steg PG, Ford I; on behalf of the BEAUTIFUL Steering Committee. Rationale and design of a randomized, double-blind, placebo-controlled trial of ivabradine in patients with stable coronary artery disease and left ventricular dysfunction: the BEAUTIFUL study. Am Heart J 2006;152:860-6.